Multiple sclerosis (MS) is a chronic inflammatory and degenerative disorder of the central nervous system (CNS). Up to 10% of adults with MS recall experiencing their first symptoms before 18 years of age, and between 2.5 and 5% of MS patients are formally diagnosed during childhood or adolescence. [1] [2] [3] [4] [5] [6] [7] The pathobiologic mechanisms underlying MS remain incompletely understood. However, there is increasing evidence that MS may be due to aberrant immunologic responses to environmental exposures experienced during childhood in genetically predisposed individuals. 8 Owing to their young age, children with MS have a shorter time window than adult patients between exposure to an environmental trigger and clinical disease onset. Appreciation of the key environmental factors is therefore vital to developing preventative strategies. In this article, we discuss the current understanding of environmental risk factors implicated in childhood-onset MS, with a focus on pediatric MS-based research.
Environmental Risk Factors for Pediatric Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disorder of the central nervous system (CNS). Up to 10% of adults with MS recall experiencing their first symptoms before 18 years of age, and between 2.5 and 5% of MS patients are formally diagnosed during childhood or adolescence. [1] [2] [3] [4] [5] [6] [7] The pathobiologic mechanisms underlying MS remain incompletely understood. However, there is increasing evidence that MS may be due to aberrant immunologic responses to environmental exposures experienced during childhood in genetically predisposed individuals. 8 Owing to their young age, children with MS have a shorter time window than adult patients between exposure to an environmental trigger and clinical disease onset. Appreciation of the key environmental factors is therefore vital to developing preventative strategies. In this article, we discuss the current understanding of environmental risk factors implicated in childhood-onset MS, with a focus on pediatric MS-based research.
Geography and Migration
The worldwide geographic distribution of adult-onset MS suggests a relationship between MS prevalence and increasing latitude [9] [10] [11] (see Figure 1 ). Latitude gradients may be observed even within a single country as reported in Australia, France, and the US. [12] [13] [14] MS in children has been reported in many countries worldwide; [1] [2] [3] [4] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] however, large-scale international collaborations will be required to determine whether global geographic patterns observed in adult-onset disease hold true in the pediatric population.
Place of residence early in life may have a significant influence on future MS risk. The prevalence of MS in individuals immigrating to England from India or Pakistan was found to be highly dependent on age at immigration, with MS being much more common in those who immigrated before 15 years of age. 28 A Canadian study examining country of birth, place of residence during childhood, and self-reported ancestry in 44 pediatric-onset and 573 adult-onset MS patients found that pediatric MS patients were more likely to report Caribbean (maternal p=0.0177; paternal p=0.0007) or Asian (maternal p<0.0001; paternal p<0.0001) ancestry compared with adult-onset MS patients, reflecting recent immigration patterns. 29 In contrast to differences in parental ancestry, there was a striking similarity in the proportion of adult-onset and pediatric-onset MS patients born in North America and in the proportion of MS patients who had spent some of or all of their childhood in Canada, suggesting that place of residence during childhood is a profound determinant of MS risk.
Vitamin D

Background
Geographical variations in MS prevalence, including observed latitude gradients, may be explained by ambient sunlight exposure and vitamin D status. In humans, the primary source of vitamin D is via cutaneous conversion of 7-dehydrocholesterol to vitamin D3, a process requiring ultraviolet B (UVB) radiation. Vitamin D3 can also be obtained through the diet, predominantly through ingestion of oily fish and fortified foods.
In the liver, vitamin D3 is converted to 25- clinical symptoms, 53 with more of an effect in female animals. 54 The mechanisms that underlie these observations may involve vitamin D-mediated interleukin-10 (IL-10) cellular signaling pathways, 55 reduced monocyte CNS entry or accumulation, 56, 57 or induction of inflammatory cell apoptosis. 58 There have been conflicting reports of the ability of UV light exposure prior to EAE induction to prevent clinical symptoms in this model. 59, 60 In human cell cultures, 1,25(OH)2D modulates monocyte functions, including antigen presentation, inhibits autoreactive T-cell activation by dendritic cells, and induces the action of regulatory T cells. [61] [62] [63] Production of pro-inflammatory cytokines such as interferon gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and IL-2 are inhibited by 1,25(OH)2D, whereas levels of anti-inflammatory cytokines such as IL-10 are enhanced.
48,61,63-69
Vitamin D-related Genetics
Several MS susceptibility loci have been identified in the human genome, with the most robust association being with specific alleles of the human leukocyte antigen (HLA) locus on chromosome 6. 70 Recently, a vitamin D response element (VDRE) was found in the promoter region of HLA-DR1 that was absolutely conserved in HLA DRB1*15 haplotypes, the major genetic risk haplotype for MS. 71 Vitamin D receptor binding sites have now been identified in 2,776 locations across the human genome, affecting the expression of 229 genes, including loci implicated as risk genes for MS. 72 These studies provide an interesting conceptual means whereby genetic susceptibility and environmental exposures may interact to increase MS risk.
Viral Exposures
Background
The powerful impact of infection on host immune behavior, the frequent similarity in structure of microbial proteins and human tissue antigens, and the noted difference in host response to specific pathogens as a function of age at exposure has led to many hypotheses linking MS and infection. The general upregulation of immune responses to any infection has been considered as potentially important in increasing the likelihood of MS relapse. 73 However, it could be argued that the most compelling link between MS and a specific pathogen exists for Epstein-Barr Virus (EBV).
EBV is a DNA virus in the herpes group that has a widespread geographic distribution and infects more than 90% of individuals by adulthood. 
Pathobiologic Insights
The underlying biological mechanisms responsible for the observed epidemiologic associations between MS risk and EBV infection remain to be fully explained. Several studies in adults have shown elevated levels of intrathecal anti-EBV-VCA antibodies, 91 anti-EBNA1 antibodies, 103 and antibodies directed against the EBV protein BRRF2 in MS patients. 104 EBV may influence MS pathogenesis through cellular immune mechanisms. A study of 20 EBV seropositive MS patients and 20 seropositive healthy controls showed an increased frequency of memory CD4 + T cells, enhanced proliferation of CD4 + cells, and increased production of the proinflammatory cytokine interferon gamma in samples from MS patients. 105 Several studies have noted T-cell cross reactivity between EBV antigens and autoantigens, including myelin basic protein.
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These results would support the hypothesis that there is cross-reactivity between EBV viral epitopes and self-antigens.
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Other Viruses
There has been interest in other potential viral etiologies for MS, including varicella zoster virus (VZV) infection. 
Cigarette Smoke
Epidemiology
Increased risk for adult-onset MS in individuals who report a history of smoking has been found in several case-control and prospective studies [116] [117] [118] [119] [120] [121] and the relative risk for MS in patients with a past or current smoking history versus those with no smoking history has been estimated to be 1.2 (95% CI 0.9-1.6) and 1. 
Pathobiologic Insights
Cigarette smoke exposure may affect MS biology in several ways.
Nicotine may alter blood-brain barrier permeability, and thus allow immune cells to enter the nervous system more readily. 127 Cyanide, a component of cigarette smoke, may be directly toxic to CNS white matter. 128 Exposure to cigarette smoke in childhood may also increase frequency of viral infections. 129 
Conclusions
There are marked variations in worldwide MS prevalence. While genetic predisposition no doubt plays a role, environmental factors such as ambient sunlight exposure, dietary vitamin D intake, age and frequency of viral infection, and exposure to cigarette smoke also likely contribute to regional differences in MS risk ( Table 1 
